Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup> Lu-Dotatate in the Phase III NETTER-1 Trial
This is a bibliographic discovery service. A title or citation count does not mean that we read the full paper or assessed its findings.
Translation pending · source title
- Authors
- Jonathan Strosberg, Edward Wolin, Beth Chasen, Matthew Kulke, David Bushnell, Martyn Caplin, Richard P. Baum, Pamela Kunz, Timothy Hobday, Andrew Hendifar, Kjell Oberg, Maribel Lopera Sierra
- Published
- September 1, 2018
- Journal or source
- Journal of Clinical Oncology
Public access status is not confirmed.
We do not store or republish full text or abstracts. We do not yet provide analysis based on reviewed full text.
Publisher record